Recognition of Research and Development Expenses
First written in FY2017-Q2. 11 of 37 entries say "Restated". Latest entry: FY2027-H1.
92 other companies' latest entry also says "Other".
- FY2027-H1Higher Research and Development Expenses for the Interim PeriodAnnual report
「Total R&D expenses for the interim cumulative consolidated period were ¥373.452 million.」
R&D expenses for the interim cumulative consolidated period were ¥373.452 million, up from ¥339.908 million in the same period of the previous year. - FY2026Full-year decrease in R&D expensesAnnual report
「Total R&D expenses incurred by the Group during the consolidated fiscal year were ¥606.097 million.」
Full-year R&D expenses were ¥606.097 million, down from ¥665.655 million in the previous fiscal year. - FY2026-H1Decline in R&D expenses for the interim periodAnnual report
「R&D expenses 339.908 Same as above 294.060 Same as above」
R&D expenses for the interim cumulative consolidated period were ¥294.060 million, down from ¥339.908 million in the same period of the previous year. - FY2025Full-year decrease in R&D expensesAnnual report
「Total R&D expenses incurred by the Group during the consolidated fiscal year were ¥660.653 million.」
Full-year R&D expenses were ¥660.653 million, down from ¥665.655 million in the previous fiscal year. - FY2025-H1Higher Research and Development Expenses for the Interim PeriodAnnual report
「R&D expenses 318.802 Same as above 339.908 Same as above」
R&D expenses for the interim cumulative consolidated period were ¥339.908 million, up from ¥318.802 million in the same period of the previous year. - FY2025-Q1First-quarter increase in R&D expensesAnnual report
「Total R&D expenses for the first quarter cumulative consolidated period were ¥161.051 million.」
R&D expenses for the first quarter cumulative consolidated period were ¥161.051 million, up from ¥143.071 million in the same period of the previous year. - FY2024Full-year increase in research and development expensesAnnual report
「Total R&D expenses incurred by the Group during the consolidated fiscal year were ¥665.655 million.」
Full-year R&D expenses were ¥665.655 million, up from ¥569.279 million in the previous fiscal year. - FY2024-Q3Third-quarter increase in R&D expensesAnnual report
「Total R&D expenses for the third quarter cumulative consolidated period were ¥489.495 million.」
R&D expenses for the third quarter cumulative consolidated period were ¥489.495 million, up from ¥409.225 million in the same period of the previous year. - FY2024-Q2Second-quarter increase in R&D expensesAnnual report
「R&D expenses 264.722 Same as above 318.802 Same as above」
R&D expenses for the second quarter cumulative consolidated period were ¥318.802 million, up from ¥264.722 million in the same period of the previous year. - FY2024-Q1First-quarter increase in R&D expensesAnnual report
「Total R&D expenses for the first quarter cumulative consolidated period were ¥143.071 million.」
R&D expenses for the first quarter cumulative consolidated period were ¥143.071 million, up from ¥122.678 million in the same period of the previous year. - FY2023Full-year increase in research and development expensesAnnual report
「Total R&D expenses incurred by the Group during the consolidated fiscal year were ¥569.279 million.」
Full-year R&D expenses were ¥569.279 million, up from ¥486.067 million in the previous fiscal year. - FY2023-Q3Third-quarter increase in R&D expensesAnnual report
「Total R&D expenses for the third quarter cumulative consolidated period were ¥409.225 million.」
R&D expenses for the third quarter cumulative consolidated period were ¥409.225 million, up from ¥368.184 million in the same period of the previous year. - FY2023-Q2Second-quarter increase in R&D expensesAnnual report
「R&D expenses 253.677 Same as above 264.722 Same as above」
R&D expenses for the second quarter cumulative consolidated period were ¥264.722 million, up from ¥253.677 million in the same period of the previous year. - FY2023-Q1First-quarter increase in R&D expensesAnnual report
「Total R&D expenses for the first quarter cumulative consolidated period were ¥122.678 million.」
R&D expenses for the first quarter cumulative consolidated period were ¥122.678 million, up from ¥122.322 million in the same period of the previous year. - FY2022Full-year increase in research and development expensesAnnual report
「Total R&D expenses incurred by the Group during the consolidated fiscal year were ¥486.067 million.」
Full-year R&D expenses were ¥486.067 million, up from ¥452.480 million in the previous fiscal year. - FY2022-Q3Third-quarter increase in R&D expensesAnnual report
「Total R&D expenses for the third quarter cumulative consolidated period were ¥368.184 million.」
R&D expenses for the third quarter cumulative consolidated period were ¥368.184 million, up from ¥357.820 million in the same period of the previous year. - FY2022-Q2Second-quarter increase in R&D expensesAnnual report
「Total R&D expenses for the second quarter cumulative consolidated period were ¥253.677 million.」
R&D expenses for the second quarter cumulative consolidated period were ¥253.677 million, up from ¥246.677 million in the same period of the previous year. - FY2022-Q1First-quarter decrease in R&D expensesAnnual report
「Total R&D expenses for the first quarter cumulative consolidated period were ¥122.322 million.」
R&D expenses for the first quarter cumulative consolidated period were ¥122.322 million, down from ¥125.625 million in the same period of the previous year. - FY2021Full-year decrease in R&D expensesAnnual report
「Total R&D expenses incurred by the Group during the consolidated fiscal year were ¥452.480 million.」
Full-year R&D expenses were ¥452.480 million, down from ¥484.682 million in the previous fiscal year. - FY2021-Q3Third-quarter increase in research and development expensesAnnual report
「Total R&D expenses for the third quarter cumulative consolidated period were ¥357.820 million.」
R&D expenses for the third quarter cumulative consolidated period were disclosed at ¥357.820 million, up from ¥294.747 million in the same period of the previous year. - FY2021-Q2Second-quarter increase in research and development expensesAnnual report
「Total research and development expenses for the cumulative period of the second quarter on a consolidated basis were ¥246.677 million.」
Total R&D expenses for the second quarter cumulative consolidated period were ¥246.677 million, up from ¥227.442 million in the same period of the previous year. - FY2021-Q1First-quarter increase in research and development expensesAnnual report
「Total research and development expenses for the cumulative period of the first quarter on a consolidated basis were ¥125.625 million.」
The company disclosed total consolidated research and development expenses of ¥125.625 million for the cumulative period of the first quarter, an increase from ¥113.203 million in the same period of the previous fiscal year. - FY2020Full-year increase in research and development expensesAnnual report
「Total research and development expenses incurred by the Group during the consolidated fiscal year were ¥484.682 million.」
Full-year research and development expenses were ¥484.682 million, an increase from ¥408.913 million in the previous fiscal year. - FY2020-Q3Third-quarter increase in research and development expensesAnnual report
「Total research and development expenses for the cumulative period of the third quarter on a consolidated basis were ¥363.908 million.」
The company disclosed total consolidated research and development expenses of ¥363.908 million for the cumulative period of the third quarter, an increase from ¥294.747 million in the same period of the previous fiscal year. - FY2020-Q2RestatedAnnual report
「Total research and development expenses for the cumulative period of the second quarter on a consolidated basis were ¥227.442 million.」
The company disclosed total consolidated research and development expenses of ¥227.442 million for the cumulative period of the second quarter. - FY2020-Q1RestatedAnnual report
「Total research and development expenses for the cumulative period of the first quarter on a consolidated basis were ¥113.203 million.」
The company disclosed total consolidated research and development expenses of ¥113.203 million for the cumulative period of the first quarter. - FY2019Full-year increase in research and development expensesAnnual report
「Total research and development expenses incurred by the Group during the consolidated fiscal year were ¥408.913 million.」
The company disclosed full-year research and development expenses of ¥408.913 million. A simple comparison with the previous fiscal year's ¥302.414 million was not made because the scope of consolidation differed. - FY2019-Q3RestatedAnnual report
「Total research and development expenses for the cumulative period of the third quarter on a consolidated basis were ¥294.747 million.」
The company disclosed total consolidated research and development expenses of ¥294.747 million for the cumulative period of the third quarter. - FY2019-Q2RestatedAnnual report
「Total research and development expenses for the cumulative period of the second quarter on a consolidated basis were ¥178.96 million.」
The company disclosed total consolidated research and development expenses of ¥178.96 million for the cumulative period of the second quarter. - FY2019-Q1RestatedAnnual report
「Total research and development expenses for the cumulative period of the first quarter on a consolidated basis were ¥84.929 million.」
The company disclosed total consolidated research and development expenses of ¥84.929 million for the cumulative period of the first quarter. - FY2018RestatedAnnual report
「Total research and development expenses incurred by the company during the fiscal year were ¥302.414 million.」
The company disclosed full-year research and development expenses of ¥302.414 million. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the cumulative period of the third quarter were ¥234.962 million.」
The company disclosed total research and development expenses of ¥234.962 million for the cumulative period of the third quarter. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the cumulative period of the second quarter were ¥157.642 million.」
The company disclosed total research and development expenses of ¥157.642 million for the cumulative period of the second quarter. - FY2018-Q1RestatedAnnual report
「Total research and development expenses for the cumulative period of the first quarter were ¥87.733 million.」
The company disclosed total research and development expenses of ¥87.733 million for the cumulative period of the first quarter. - FY2017RestatedAnnual report
「Total research and development expenses incurred by the company during the fiscal year were ¥363.641 million.」
The company disclosed full-year research and development expenses of ¥363.641 million. - FY2017-Q3RestatedAnnual report
「Total research and development expenses for the cumulative period of the third quarter were ¥283.201 million.」
The company disclosed total research and development expenses of ¥283.201 million for the cumulative period of the third quarter. - FY2017-Q2First statedAnnual report
「Total research and development expenses for the cumulative second quarter under review were ¥175,742 thousand.」
The disclosure reports total research and development expenses for the cumulative second quarter under review.